Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

Background: Emerging evidence shows that coronavirus disease 2019 (COVID-19) is
commonly complicated by coagulopathy, and venous thromboembolism (VTE) is considered …

Background: Coagulopathy associated with COVID-19 infection and venous
thromboembolism (VTE) have emerged as significant contributors to morbidity among …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

Background The incidence of venous thromboembolic events (VTE) in patients with COVID-
19 is generally high but varies markedly. However, the relationship between anticoagulation …

Background Many studies confirmed an association between COVID-19 and venous
thromboembolism (VTE). Whether the risk of VTE significantly differed between COVID-19 …

Background Patients with COVID-19 infection are commonly reported to have an increased
risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently …

Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations,
leading in some cases to a critical condition with poor long-term outcomes and residual …

Venous thromboembolism (VTE) in patients with COVID-19 in intensive care units (ICU) is
frequent, but risk factors (RF) remain unidentified. In this meta-analysis (CRD42020188764) …

Abstract Purpose Coronavirus disease‐2019 (COVID‐19) may predispose to venous
thromboembolism (VTE) and arterial thromboembolism because of excessive inflammation …